ENDRA Life Sciences (NDRA) Other Non-Current Liabilities (2024 - 2026)

ENDRA Life Sciences has disclosed Other Non-Current Liabilities across 3 years of filings, most recently posting $488604.0 for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $488604.0; the TTM figure through Mar 2026 stood at $488604.0 (changed N/A YoY), while the FY2025 annual figure was $479747.0, down 39.98% from the prior year.
• Other Non-Current Liabilities improved to $488604.0 in Q1 2026, from $479747.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for NDRA reached as high as $799284.0 in Q4 2024 and fell as low as $479747.0 in Q4 2025.
• The 3-year median for Other Non-Current Liabilities is $542244.0 (2025), against an average of $590879.8.
• The widest YoY moves for Other Non-Current Liabilities: up 39.98% in 2025, down 39.98% in 2025.
• A 3-year view of Other Non-Current Liabilities shows it stood at $799284.0 in 2024, then tumbled by 39.98% to $479747.0 in 2025, then advanced by 1.85% to $488604.0 in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $488604.0, $479747.0, and $595884.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.